Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

Patients with stage I or II hormone receptor-negative breast cancer do not benefit from preoperative breast MRI, according to ...

Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

Initial breast surgery was initial BCS in 91.2% of the MRI arm and 92.7% of the no MRI arm; axillary surgery was sentinel lymph node biopsy alone in 86.4% and 94.7%, respectively; final margin status ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

Contrast chemicals injected into people for medical imaging scans are likely contributing to water pollution, a new study ...

MRI with a 15-channel dental coil detects bone invasion with superior accuracy in patients with head and neck cancer, a ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

The White House released a statement on Dec. 1 from President Donald Trump's physician regarding his MRI scan. Here's what to ...

Onsite Women's Health is exploring a new imaging technology that could help patients avoid the long waits, high costs and ...

CHARLESTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a life sciences company developing precision genetic medicines for neuromuscular ...

CEM serves as a faster, more accessible alternative to breast MRI while providing similar diagnostic accuracy. The technology is particularly valuable for evaluating abnormalities, staging cancer, ...